These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 19089697)

  • 1. Antidepressant direct-to-consumer advertising and social perception of the prevalence of depression: application of the availability heuristic.
    An S
    Health Commun; 2008 Nov; 23(6):499-505. PubMed ID: 19089697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct-to-consumer advertising (DTCA) for prescription drugs: consumers' attitudes and preferences concerning its regulation in South Korea.
    Suh HS; Lee D; Kim SY; Chee DH; Kang HY
    Health Policy; 2011 Aug; 101(3):260-8. PubMed ID: 21705104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct-to-consumer advertising skepticism and the use and perceived usefulness of prescription drug information sources.
    DeLorme DE; Huh J; Reid LN
    Health Mark Q; 2009; 26(4):293-314. PubMed ID: 19916096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of direct-to-consumer advertising in shaping public opinion surrounding prescription drug use to treat depression or anxiety in youth.
    Martinez LS; Lewis N
    J Health Commun; 2009; 14(3):246-61. PubMed ID: 19440908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of direct-to-consumer television and magazine advertising on antidepressant use.
    Avery RJ; Eisenberg MD; Simon KI
    J Health Econ; 2012 Sep; 31(5):705-18. PubMed ID: 22835472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Third-person effects and direct-to-consumer advertisements for antidepressants.
    Taylor LD; Bell RA; Kravitz RL
    Depress Anxiety; 2011 Feb; 28(2):160-5. PubMed ID: 21284069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct-to-consumer antidepressant advertising and consumers' optimistic bias about the future risk of depression: the moderating role of advertising skepticism.
    Park JS; Ju I; Kim KE
    Health Commun; 2014; 29(6):586-97. PubMed ID: 23790180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attitude toward direct-to-consumer advertising and drug inquiry intention: the moderating role of perceived knowledge.
    An S
    J Health Commun; 2007 Sep; 12(6):567-80. PubMed ID: 17763053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consumers young and old: segmenting the target markets for direct-to-consumer prescription drug advertising.
    Ball JG; Manika D; Stout P
    Health Mark Q; 2011 Oct; 28(4):337-53. PubMed ID: 22054029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Social inequality in the prevalence of depressive disorders.
    Andersen I; Thielen K; Nygaard E; Diderichsen F
    J Epidemiol Community Health; 2009 Jul; 63(7):575-81. PubMed ID: 19293167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct-to-consumer advertising and its utility in health care decision making: a consumer perspective.
    Deshpande A; Menon A; Perri M; Zinkhan G
    J Health Commun; 2004; 9(6):499-513. PubMed ID: 15764449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antidepressants consumption in the global population in France].
    Olié JP; Elomari F; Spadone C; Lépine JP
    Encephale; 2002; 28(5 Pt 1):411-7. PubMed ID: 12386542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marketing drugs, marketing health care relationships: a content analysis of visual cues in direct-to-consumer prescription drug advertising.
    Welch Cline RJ; Young HN
    Health Commun; 2004; 16(2):131-57. PubMed ID: 15090282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression diagnoses and antidepressant use in primary care practices: a study from the Practice Partner Research Network (PPRNet).
    Ornstein S; Stuart G; Jenkins R
    J Fam Pract; 2000 Jan; 49(1):68-72. PubMed ID: 10678342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of social support at work and in private life with mental health and antidepressant use: the Health 2000 Study.
    Sinokki M; Hinkka K; Ahola K; Koskinen S; Kivimäki M; Honkonen T; Puukka P; Klaukka T; Lönnqvist J; Virtanen M
    J Affect Disord; 2009 May; 115(1-2):36-45. PubMed ID: 18722019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introduction of direct-to-consumer advertising of prescription drugs in Canada: an opinion survey on regulatory policy.
    Mintzes B; Barer M; Lexchin J; Bassett KL
    Res Social Adm Pharm; 2005 Jun; 1(2):310-30. PubMed ID: 17138480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costs and benefits of direct-to-consumer advertising: the case of depression.
    Block AE
    Pharmacoeconomics; 2007; 25(6):511-21. PubMed ID: 17523755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study.
    Kerchner A; Lester W; Stuart SP; Dokras A
    Fertil Steril; 2009 Jan; 91(1):207-12. PubMed ID: 18249398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical Test of the Beneficial Consequences of Lifting the Ban on Direct-to-Consumer Advertising for Prescription Drugs in Italy: Experimental Exposure and Questionnaire Study.
    Schulz PJ; Crosignani F; Petrocchi S
    J Med Internet Res; 2023 Jul; 25():e40616. PubMed ID: 37459159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDA direct-to-consumer advertising for prescription drugs: what are consumer preferences and response tendencies?
    Khanfar N; Loudon D; Sircar-Ramsewak F
    Health Mark Q; 2007; 24(1-2):77-91. PubMed ID: 19042521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.